The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra ...

The result puts Scholar Rock out in front of a small group of drugmakers developing myostatin-targeting drugs for SMA, alongside Biohaven's recombinant protein drug taldefegrobep alfa – in the ...

A previously unknown protein in a family of bacteria found in soil and the human gut microbiome has been discovered—which ...

Overview: Kexing Biopharm Co., Ltd. focuses on the research, development, production, and sale of recombinant protein drugs and microbial preparations both in China and internationally ...

The Global Recombinant Chemicals Market is valued at approximately USD 2.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2024-2032.

the first biosynthetic insulin produced by recombinant DNA technology was granted approval by the United States’ Food and Drug Administration (FDA) and heralded a new era in protein therapeutics.

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

The bioengineered protein drugs market is experiencing a paradigm shift, with pharmaceutical and biotech companies leveraging advanced biopharmaceuti ...